Authors: DIBISCEGLIE AM BABBITT BP MIESOWICZ F SCHRATZ CL OSMACK PA BACON BR

Citation: Am. Dibisceglie et al., A PILOT-STUDY OF AUTOLOGOUS LYMPHOCYTE THERAPY FOR CHRONIC HEPATITIS-B, Gastroenterology, 112(4), 1997, pp. 1257-1257

Authors: MIESOWICZ F DUMOULIN G LIU V HAMILTON D DAVIES B PITKIN Z STACK A CHEWDARKE J OSBAND M

Citation: F. Miesowicz et al., DEVELOPMENT AND IMPLEMENTATION OF DELIVERY AND QUALITY-CONTROL SYSTEMFOR CELLULAR THERAPIES - EXPERIENCE IN 500 PATIENTS, Cell transplantation, 3, 1994, pp. 190000053-190000053

Authors: ROSS SD LAVIN PT MARTIN J MIESOWICZ F OSBAND ME

Citation: Sd. Ross et al., A STATISTICAL-MODEL TO PREDICT OUTCOME IN PATIENTS WITH METASTATIC RENAL-CELL CANCER (RCC) TREATED WITH AUTOLYMPHOCYTE THERAPY (ALT), The Journal of immunology, 150(8), 1993, pp. 217-217

Authors: ZHANG ZJ KURTZBERG L OSBAND M MIESOWICZ F BABBITT B

Citation: Zj. Zhang et al., SYNERGISTIC EFFECTS OF AUTOLOGOUS CYTOKINES AND OKT3 IN THE EXVIVO ACTIVATION OF MEMORY T-LYMPHOCYTES UTILIZED IN ADOPTIVE IMMUNOTHERAPY OFMETASTATIC RENAL-CELL CARCINOMA, The Journal of immunology, 150(8), 1993, pp. 218-218

Authors: CAPLAN B GOODWIN J OSBAND M MIESOWICZ F BABBITT B

Citation: B. Caplan et al., EXVIVO ACTIVATED MEMORY T-CELLS USED IN AUTOLYMPHOCYTE THERAPY OF METASTATIC RENAL-CELL CARCINOMA PROLIFERATE AND PRODUCE CYTOKINES IN RESPONSE TO PMA, The Journal of immunology, 150(8), 1993, pp. 280-280